We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

24 hedge funds and large institutions have $8.61M invested in Assembly Biosciences in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $7.12M → $8.61M (+$1.49M)

10.71% more ownership

Funds ownership: 1.1% → 11.81% (+11%)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

45% less funds holding

Funds holding: 44 → 24 (-20)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
24
Holders Change
-20
Holders Change %
-45.45%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
10
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AI
Acuitas Investments
Washington
+$322K
2
MAM
Marquette Asset Management
Minnesota
+$52.2K
3
Millennium Management
Millennium Management
New York
+$47.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$41.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$16.8K

Top Sellers

1
AFM
Anson Funds Management
Texas
-$590K
2
Two Sigma Investments
Two Sigma Investments
New York
-$111K
3
Citadel Advisors
Citadel Advisors
Florida
-$102K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$58.9K
5
Franklin Resources
Franklin Resources
California
-$53.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.61M +$16.8K +1,444 +0.7%
Millennium Management
2
Millennium Management
New York
$1.66M +$47.6K +4,085 +3%
BlackRock
3
BlackRock
New York
$1.04M -$12.1K -1,038 -1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$694K +$13.9K +1,196 +2%
AI
5
Acuitas Investments
Washington
$661K +$322K +27,600 +125%
Renaissance Technologies
6
Renaissance Technologies
New York
$525K +$41.8K +3,584 +10%
Federated Hermes
7
Federated Hermes
Pennsylvania
$338K -$12 -1 -0%
BCM
8
Bridgeway Capital Management
Texas
$193K – – –
State Street
9
State Street
Massachusetts
$161K -$23 -2 -0%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$151K -$501 -43 -0.4%
Northern Trust
11
Northern Trust
Illinois
$140K -$4.35K -373 -3%
MAM
12
Marquette Asset Management
Minnesota
$120K +$52.2K +4,477 +99%
Amundi
13
Amundi
France
$106K – – –
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$78K – – –
UBS Group
15
UBS Group
Switzerland
$43K +$14.2K +1,221 +61%
Barclays
16
Barclays
United Kingdom
$39.8K – – –
Morgan Stanley
17
Morgan Stanley
New York
$32.9K -$30.7K -2,638 -52%
TRCT
18
Tower Research Capital (TRC)
New York
$11.4K -$2.62K -225 -21%
RhumbLine Advisers
19
RhumbLine Advisers
Massachusetts
$2.65K -$12 -1 -0.5%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$1K +$385 +33 +72%
EWA
21
EverSource Wealth Advisors
Alabama
$686 – – –
Wells Fargo
22
Wells Fargo
California
$585 +$23 +2 +5%
JP Morgan Chase
23
JP Morgan Chase
New York
$93 -$12 -1 -13%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$40 -$12 -1 -25%
AFM
25
Anson Funds Management
Texas
– -$590K -59,956 Closed
1
2

ASMB Hedge Fund Activity: Q1 2024 in Review

24 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2024, worth a combined $8.61M — up 21% from $7.12M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ASMB and 0 opened new positions — a net loss of 20 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Acuitas Investments, adding an estimated $322K. The largest seller was Anson Funds Management, exiting entirely with an estimated $590K sold.

  • 24 institutional investors held Assembly Biosciences (ASMB) as of Q1 2024, down from 44 in Q4 2023.
  • Funds reported $8.61M of Assembly Biosciences stock for Q1 2024, up 21% quarter-over-quarter.
  • 0 funds opened new Assembly Biosciences positions in Q1 2024 and 20 closed out, a net change of -20 holders.
  • The largest Assembly Biosciences buyer in Q1 2024 was Acuitas Investments, an estimated $322K added.
  • The largest Assembly Biosciences seller in Q1 2024 was Anson Funds Management, an estimated $590K sold.

Based on aggregated 13F filings for Q1 2024.